The number of people with susceptibility test result for rifampicin in Kenya

Kenya: The number of people with susceptibility test result for rifampicin was 24,832 in 2021. ▬ Flat

Latest (2021)
24,832
Change on year
down 24.2%
World rank
13th
of 155 countries
All-time high
33,149
in 2019
All-time low
24,832
in 2021
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Kenya, 2017–2021

010.0k20.0k30.0k2017201920212017: 28.3k2018: 28.3k2019: 33.1k2020: 32.8k2021: 24.8k

Source: World Health Organization, Global Health Observatory.

Analysis

Kenya recorded 24,832 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.

Compared with earlier readings it is down 24.2% on the previous year and down 12.3% over five years.

Kenya ranks 13th of 155 countries on this measure, in the top 10%.

The number of people with susceptibility test result for rifampicin in Kenya, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Kenya, 2017 to 2021.
Year Value Change
2017 28,316
2018 28,284 -0.1%
2019 33,149 +17.2%
2020 32,771 -1.1%
2021 24,832 -24.2%

Kenya compared with similar countries

  • Kenya's 24,832 is above the median for lower middle income countries, which is 2,804, 8.9× the median. (32 countries reporting)
  • Kenya's 24,832 is above the median for Sub-Saharan Africa, which is 2,015, 12.3× the median. (33 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 29,916 28,284 33,149 3
2020s 28,802 24,832 32,771 2

Countries ranked near Kenya

  1. 10 Congo, Democratic Republic of the 28,577 compare
  2. 11 Uganda 28,418 compare
  3. 12 Tanzania, United Republic of 26,624 compare
  4. 14 Brazil 24,394 compare
  5. 15 Russian Federation 21,391 compare
  6. 16 Afghanistan 17,443 compare

See the full ranking of 157 places →

More health data for Kenya

All data for Kenya →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Kenya?
The number of people with susceptibility test result for rifampicin in Kenya was 24,832 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Kenya?
The highest recorded value was 33,149 in 2019.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Kenya?
The lowest recorded value was 24,832 in 2021.
How does Kenya rank for the number of people with susceptibility test result for rifampicin?
Kenya ranks 13th out of 155 countries with data for 2021.
Where does this Kenya data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Kenya. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 15 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/kenya/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/kenya/">The number of people with susceptibility test result for rifampicin in Kenya</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed